PARP1 and cancer: A second PARP inhibitor, PJ-34, is currently undergoing pre-clinical trials and is known to induce distorted multipolar spindles and to disrupt bipolar clustering of extra centrosomes resulting in mitotic catastrophe and cell death, an effect exclusively eradicating cancer cells harbouring CA without affecting normal cell proliferation [124,132,150].